bf/NASDAQ:REGN_icon.jpeg

NASDAQ:REGN

Regeneron Pharmaceuticals, Inc.

  • Stock

USD

Last Close

937.61

03/05 20:00

Market Cap

100.71B

Beta: 0.23

Volume Today

525.88K

Avg: 576.83K

PE Ratio

25.31

PFCF: 33.11

Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
49.50M
-
99.61M
101.24%
183.72M
84.44%
318.97M
73.62%
562.75M
76.43%
938.67M
66.80%
1.28B
36.72%
1.67B
29.82%
1.93B
16.08%
2.18B
12.55%
average payables
50.44M
-
80.72M
60.05%
120.23M
48.95%
137.97M
14.75%
156.58M
13.49%
198.19M
26.57%
318.15M
60.53%
446.80M
40.44%
519.75M
16.33%
576.60M
10.94%
average receivables
792.45M
-
954.59M
20.46%
1.24B
30.17%
1.54B
23.91%
1.79B
16.45%
2.11B
17.61%
2.46B
16.55%
3.39B
38.07%
5.08B
49.57%
5.68B
11.96%
book value per share
19.94
-
25.27
26.75%
35.46
40.34%
42.49
19.81%
57.78
35.99%
81.16
40.47%
101.55
25.13%
102.47
0.90%
177.57
73.29%
211.62
19.18%
capex per share
-1.60
-
-3.31
107.32%
-6.58
98.74%
-4.89
25.68%
-2.56
47.56%
-3.55
38.49%
-3.93
10.80%
-5.71
45.19%
-5.22
8.59%
-15.10
189.14%
-5.53
63.37%
capex to depreciation
-3.79
-
-6.32
66.60%
-9.05
43.18%
-4.89
46.00%
-1.87
61.65%
-2.59
37.93%
-2.04
20.98%
-2.61
27.54%
-1.93
25.98%
-4.74
145.60%
capex to operating cash flow
-0.27
-
-0.45
67.30%
-0.51
13.69%
-0.35
31.79%
-0.21
39.97%
-0.17
16.32%
-0.18
1.30%
-0.23
32.78%
-0.08
66.80%
-0.32
313.69%
-0.12
63.50%
capex to revenue
-0.07
-
-0.12
59.02%
-0.17
39.87%
-0.11
36.24%
-0.05
55.92%
-0.06
22.96%
-0.05
4.30%
-0.07
32.39%
-0.03
52.52%
-0.13
286.80%
-0.04
66.13%
cash per share
7.09
-
8.95
26.28%
10.14
13.32%
9.92
2.20%
13.26
33.64%
26.04
96.46%
29.43
13.03%
33.34
13.25%
53.88
61.61%
72.29
34.18%
days of inventory on hand
165.29
-
229.42
38.79%
221.74
3.34%
486.38
119.34%
667.51
37.24%
967.95
45.01%
660.52
31.76%
624.66
5.43%
292.19
53.22%
561.84
92.28%
days payables outstanding
145.52
-
177.16
21.74%
131.02
26.05%
164.40
25.48%
163.80
0.37%
183.47
12.01%
195.10
6.34%
154.98
20.57%
84.46
45.50%
137.82
63.19%
days sales outstanding
154.65
-
131.71
14.84%
130.55
0.88%
121.03
7.30%
122.72
1.40%
122.01
0.58%
124.04
1.66%
176.75
42.50%
137.09
22.44%
159.78
16.55%
debt to assets
0.17
-
0.21
21.79%
0.15
29.36%
0.09
40.91%
0.13
53.31%
0.05
60.65%
0.05
8.40%
0.25
422.82%
0.13
46.67%
0.12
12.89%
debt to equity
0.26
-
0.32
22.69%
0.23
28.82%
0.14
39.65%
0.19
39.53%
0.07
63.03%
0.06
8.73%
0.39
509.63%
0.18
53.58%
0.15
17.14%
dividend yield
0.01
-
0.01
37.12%
0.01
32.97%
0.01
31.05%
earnings yield
0.02
-
0.01
46.44%
0.01
34.81%
0.02
104.91%
0.03
28.69%
0.06
102.32%
0.05
14.92%
0.07
30.97%
0.12
79.00%
0.06
53.59%
0.04
24.86%
enterprise value
26.92B
-
41.09B
52.62%
55.52B
35.12%
38.39B
30.85%
39.87B
3.86%
39.54B
0.82%
40.10B
1.41%
52.48B
30.89%
66.57B
26.83%
77.59B
16.56%
enterprise value over ebitda
35.42
-
49.00
38.35%
44.34
9.51%
28.85
34.95%
19.17
33.54%
15.60
18.62%
18.15
16.30%
13.57
25.21%
7.09
47.73%
15.00
111.41%
ev to operating cash flow
46.12
-
55.29
19.86%
41.72
24.55%
26.05
37.55%
30.50
17.07%
18.01
40.94%
16.50
8.39%
20.05
21.49%
9.40
53.11%
15.47
64.58%
ev to sales
12.79
-
14.57
13.93%
13.53
7.16%
7.90
41.62%
6.79
14.03%
5.89
13.22%
5.10
13.46%
6.18
21.13%
4.14
32.95%
6.37
53.89%
free cash flow per share
4.36
-
4.08
6.59%
6.33
55.39%
9.18
44.94%
9.73
5.96%
16.79
72.62%
18.32
9.08%
18.62
1.64%
61.77
231.76%
31.73
48.64%
41.47
30.71%
free cash flow yield
0.02
-
0.01
37.33%
0.01
17.43%
0.03
114.34%
0.03
3.46%
0.04
73.76%
0.05
8.51%
0.04
21.00%
0.10
153.79%
0.04
55.04%
0.05
7.37%
graham net net
4.08
-
3.96
2.82%
3.02
23.79%
-0.74
124.41%
5.95
908.30%
19.38
225.40%
20.24
4.48%
13.88
31.45%
42.87
208.92%
59.66
39.15%
graham number
44.09
-
44.35
0.59%
70.17
58.23%
90.42
28.85%
121.05
33.88%
203.40
68.03%
210.41
3.45%
274.36
30.39%
552.48
101.37%
439.17
20.51%
income quality
1.38
-
2.14
55.24%
2.09
2.01%
1.65
21.36%
1.09
33.71%
0.90
17.66%
1.15
27.89%
0.75
35.11%
0.88
17.67%
1.16
31.82%
intangibles to total assets
-0.21
-
-0.12
43.59%
-0.11
5.17%
-0.12
9.97%
-0.17
36.85%
-0.15
11.82%
-0.22
47.08%
-0.18
16.95%
-0.27
47.16%
0.03
111.66%
0
100%
interest coverage
16.37
-
22.43
37.07%
87.91
291.84%
184.95
110.39%
82.79
55.24%
89.87
8.56%
73.17
18.58%
62.86
14.10%
156.14
148.40%
79.78
48.91%
-55.44
169.49%
interest debt per share
5.65
-
8.41
49.03%
8.17
2.87%
5.88
28.08%
11.26
91.55%
5.99
46.84%
6.81
13.83%
40.74
497.90%
32.89
19.27%
32.50
1.19%
inventory turnover
2.21
-
1.59
27.95%
1.65
3.46%
0.75
54.41%
0.55
27.13%
0.38
31.04%
0.55
46.54%
0.58
5.74%
1.25
113.78%
0.65
47.99%
invested capital
0.26
-
0.32
22.69%
0.23
28.82%
0.14
39.65%
0.19
39.53%
0.07
63.03%
0.06
8.73%
0.39
509.63%
0.18
53.58%
0.15
17.14%
market cap
26.95B
-
41.28B
53.15%
55.95B
35.55%
38.44B
31.29%
39.98B
4.00%
40.30B
0.80%
41.00B
1.74%
51.98B
26.78%
66.75B
28.41%
77.27B
15.76%
93.71B
21.28%
net current asset value
1.25B
-
1.18B
6.05%
1.43B
21.41%
1.39B
2.78%
2.98B
114.17%
4.98B
67.39%
6.84B
37.36%
6.62B
3.32%
13.85B
109.41%
15.51B
11.98%
net debt to ebitda
-0.04
-
-0.23
471.24%
-0.35
53.11%
-0.04
88.27%
-0.05
29.31%
-0.30
470.06%
-0.41
36.55%
0.13
131.73%
-0.02
115.26%
0.06
407.82%
net income per share
4.33
-
3.46
20.17%
6.17
78.39%
8.55
38.56%
11.27
31.80%
22.65
101.00%
19.38
14.47%
32.65
68.52%
76.40
133.99%
40.51
46.98%
37.05
8.53%
operating cash flow per share
5.96
-
7.39
23.92%
12.91
74.82%
14.07
8.96%
12.29
12.64%
20.34
65.50%
22.25
9.38%
24.33
9.34%
66.99
175.34%
46.82
30.11%
47
0.37%
payables turnover
2.51
-
2.06
17.86%
2.79
35.22%
2.22
20.31%
2.23
0.37%
1.99
10.72%
1.87
5.96%
2.36
25.89%
4.32
83.50%
2.65
38.72%
receivables turnover
2.36
-
2.77
17.42%
2.80
0.88%
3.02
7.87%
2.97
1.38%
2.99
0.58%
2.94
1.64%
2.07
29.82%
2.66
28.93%
2.28
14.20%
research and ddevelopement to revenue
0.41
-
0.45
10.36%
0.39
12.42%
0.42
6.92%
0.35
16.31%
0.33
7.82%
0.39
18.54%
0.32
16.65%
0.18
43.78%
0.30
63.10%
0.34
14.67%
return on tangible assets
0.12
-
0.08
32.35%
0.10
26.83%
0.11
12.12%
0.12
2.33%
0.18
54.99%
0.12
35.36%
0.17
47.75%
0.25
44.57%
0.15
38.73%
revenue per share
21.50
-
28.02
30.37%
39.82
42.09%
46.41
16.56%
55.22
18.98%
62.19
12.63%
72.01
15.78%
78.97
9.67%
152.05
92.54%
113.66
25.25%
122.94
8.16%
roe
0.22
-
0.14
37.02%
0.17
27.11%
0.20
15.65%
0.20
3.08%
0.28
43.09%
0.19
31.65%
0.32
67.02%
0.43
35.02%
0.19
55.51%
roic
0.17
-
0.10
39.96%
0.13
30.58%
0.16
20.67%
0.15
7.59%
0.24
60.92%
0.15
36.09%
0.21
33.46%
0.34
64.80%
0.16
53.32%
sales general and administrative to revenue
0.16
-
0.18
14.38%
0.20
14.14%
0.24
18.58%
0.22
7.20%
0.23
3.13%
shareholders equity per share
19.94
-
25.27
26.75%
35.46
40.34%
42.49
19.81%
57.78
35.99%
81.16
40.47%
101.55
25.13%
102.47
0.90%
177.57
73.29%
211.62
19.18%
stock based compensation to revenue
0.09
-
0.11
15.60%
0.11
2.66%
0.12
2.98%
0.09
25.01%
0.06
26.27%
0.06
7.29%
0.05
13.90%
0.04
26.36%
0.06
59.08%
tangible asset value
2.57B
-
3.00B
16.65%
4.29B
42.78%
5.31B
23.94%
7.63B
43.61%
10.51B
37.77%
14.35B
36.47%
14.16B
1.29%
25.61B
80.83%
21.75B
15.07%
tangible book value per share
19.94
-
25.27
26.75%
35.46
40.34%
42.49
19.81%
57.78
35.99%
81.16
40.47%
101.55
25.13%
102.47
0.90%
177.57
73.29%
203.07
14.36%
working capital
1.99B
-
1.89B
5.19%
2.62B
39.03%
2.93B
11.82%
4.63B
57.82%
6.61B
42.73%
8.77B
32.70%
9.95B
13.45%
17.07B
71.60%
18.22B
6.71%

All numbers in USD (except ratios and percentages)